These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 2688406)
41. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia. Wegmüller E; Montandon A; Nydegger U; Descoeudres C Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914 [TBL] [Abstract][Full Text] [Related]
42. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. McCarthy JT; Jenson BM; Squillace DP; Williams AW Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048 [TBL] [Abstract][Full Text] [Related]
43. Phagocyte metabolic activity during hemodialysis with different dialyzers not affecting the number of circulating phagocytes. Vanholder R; Van Landschoot N; Waterloos MA; Delanghe J; Van Maele G; Ringoir S Int J Artif Organs; 1992 Feb; 15(2):89-92. PubMed ID: 1555881 [TBL] [Abstract][Full Text] [Related]
44. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration. Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678 [TBL] [Abstract][Full Text] [Related]
45. The next generation of dialysis membranes--barriers or pathways? Streicher E; Schneider H Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283 [No Abstract] [Full Text] [Related]
46. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers. Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127 [TBL] [Abstract][Full Text] [Related]
47. Difference in beta 2-microglobulin removal between cellulosic and synthetic polymer membrane dialyzers. Mineshima M; Hoshino T; Era K; Kitano Y; Suzuki T; Sanaka T; Teraoka S; Agishi T; Ota K ASAIO Trans; 1990; 36(3):M643-6. PubMed ID: 2252773 [TBL] [Abstract][Full Text] [Related]
48. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients. Wanner C; Bahner U; Mattern R; Lang D; Passlick-Deetjen J Nephrol Dial Transplant; 2004 Oct; 19(10):2570-5. PubMed ID: 15280524 [TBL] [Abstract][Full Text] [Related]
49. Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers. Walker RJ; Sutherland WH; De Jong SA Clin Nephrol; 2004 Mar; 61(3):198-206. PubMed ID: 15077871 [TBL] [Abstract][Full Text] [Related]
50. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis]. Szepietowski T; el-Hayek A Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157 [TBL] [Abstract][Full Text] [Related]
51. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058 [TBL] [Abstract][Full Text] [Related]
52. Clinical experience and model analysis on beta-2-microglobulin kinetics in high-flux hemodialysis. Lian JD; Cheng CH; Chang YL; Hsiong CH; Lee CJ Artif Organs; 1993 Sep; 17(9):758-63. PubMed ID: 8240067 [TBL] [Abstract][Full Text] [Related]